Oxpin | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Oxpin
Health Canada Patents

PharmaCompass Sponsored Ads

Contact Supplier

Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.

Contact Supplier

pharmacompass-1-m-2025-08-25

PharmaCompass Sponsored Ads

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

pharmacompass-2-m-2025-08-25

Oxpin

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

84 API Suppliers, 27 USDMF, 15 CEP/COS, 9 EU WC, 6 KDMF, 28 NDC API, 45 Listed Suppliers, $ API Reference Price

84 API Suppliers
27 USDMF
15 CEP/COS
9 EU WC
6 KDMF
28 NDC API
45 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

11 Drugs in Development

11 Drugs in Development

INTERMEDIATES

6 Intermediate Suppliers

6 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

192 FDF Dossiers, 77 FDA Orange Book, 81 Europe, 6 Canada, 8 Australia, 2 South Africa, 18 Listed Dossiers

192 FDF Dossiers
77 FDA Orange Book
81 Europe
6 Canada
8 Australia
2 South Africa
18 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 150MG, TABLET;ORAL - 300MG, TABLET;ORAL - 600MG

TABLET;ORAL - 150MG
TABLET;ORAL - 300MG
TABLET;ORAL - 600MG

RELATED EXCIPIENT COMPANIES

1 Minakem, 2 Evonik, 4 Rochem International Inc, 7 SPI Pharma, 11 DKSH, 1 Pharm-RX Chemical, 10 Boai NKY Pharmaceuticals Ltd, 6 Gangwal Healthcare, 6 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 1 Pfanstiehl, 4 Kirsch Pharma, 1 ACG Worldwide, 8 Actylis, 1 Aeon Procare, 3 Alcedo Pharmachem, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 3 Ashland, 36 BASF, 2 CD Formulation, 1 Clariant, 13 Corel Pharma Chem, 3 DFE Pharma, 1 Esteem Industries, 2 Finar, 14 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 9 Ideal Cures, 3 Ingredion Pharma Solutions, 13 Kerry, 3 Keval Exports, 4 Kima Chemical, 6 Lonza Capsugel, 14 Microlex e.U, 1 Nanjing Bold Chemical, 3 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 5 Novo Excipients, 4 Pharmatrans-Sanaq, 5 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 25 Roquette, 16 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 3 Silverline Chemicals, 3 The Dow Chemical Company, 2 Ulanqab Kema New Material, 2 Valens Pharmachem, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

68 Coating Systems & Additives, 60 Fillers, Diluents & Binders, 40 Solubilizers, 40 Thickeners and Stabilizers, 36 Controlled & Modified Release, 33 Disintegrants & Superdisintegrants, 30 Direct Compression, 25 Granulation, 24 Film Formers & Plasticizers, 23 Topical, 21 Lubricants & Glidants, 20 Parenteral, 19 Taste Masking, 14 Rheology Modifiers, 14 Chewable & Orodispersible Aids, 14 Co-Processed Excipients, 11 Emulsifying Agents, 9 Surfactant & Foaming Agents, 8 API Stability Enhancers, 5 Coloring Agents, 5 Empty Capsules, 4 Vegetarian Capsules, 1 Soft Gelatin

68 Coating Systems & Additives
60 Fillers, Diluents & Binders
40 Solubilizers
40 Thickeners and Stabilizers
36 Controlled & Modified Release
33 Disintegrants & Superdisintegrants
30 Direct Compression
25 Granulation
24 Film Formers & Plasticizers
23 Topical
21 Lubricants & Glidants
20 Parenteral
19 Taste Masking
14 Rheology Modifiers
14 Chewable & Orodispersible Aids
14 Co-Processed Excipients
11 Emulsifying Agents
9 Surfactant & Foaming Agents
8 API Stability Enhancers
5 Coloring Agents
5 Empty Capsules
4 Vegetarian Capsules
1 Soft Gelatin

DIGITAL CONTENT

26 News #PharmaBuzz

26 News #PharmaBuzz

GLOBAL SALES INFORMATION

16 US Medicaid Prescriptions, 54 Regulatory FDF Prices, 1 Annual Reports

16 US Medicaid Prescriptions
54 Regulatory FDF Prices
1 Annual Reports

MARKET PLACE

14 APIs, 1 FDF Dossiers

14 APIs
1 FDF Dossiers

PATENTS & EXCLUSIVITIES

33 US Patents, 4 Health Canada Patents

33 US Patents
4 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 3 USP, 4 Others

2 EDQM
3 USP
4 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 176 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

4 All

01 4Gowling Strathy & Henderson

filter Patent Reset all filters

4 All

01 42277791

filter Product Reset all filters

4 All

01 4Oxcarbazepine

filter Dosage Reset all filters

4 All

01 1Oral Suspension

02 3Tablets

filter Exp Date Reset all filters

4 All

01 22008-02-12

02 22018-02-12

Nuray Oxcarbazepine

Product Main Page

01

Gowling Strathy & Henderson

Oxcarbazepine

Peptide Process CMC

Not Confirmed

Gowling Strathy & Henderson

Canada

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2018-02-12

Date Granted : 2008-11-18

Oxcarbazepine

Brand Name : TRILEPTAL

Patent Number : 2277791

Filing Date : 1998-02-12

Strength per Unit : 150mg

Dosage Form : Tablets

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2018-02-12

Date Granted : 2008-11-18

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Gowling Strathy & Henderson

Oxcarbazepine

Peptide Process CMC

Not Confirmed

Gowling Strathy & Henderson

Canada

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2008-02-12

Date Granted : 2008-11-18

Oxcarbazepine

Brand Name : TRILEPTAL

Patent Number : 2277791

Filing Date : 1998-02-12

Strength per Unit : 600mg

Dosage Form : Tablets

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2008-02-12

Date Granted : 2008-11-18

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Gowling Strathy & Henderson

Oxcarbazepine

Peptide Process CMC

Not Confirmed

Gowling Strathy & Henderson

Canada

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2008-02-12

Date Granted : 2008-11-18

Oxcarbazepine

Brand Name : TRILEPTAL

Patent Number : 2277791

Filing Date : 1998-02-12

Strength per Unit : 300mg

Dosage Form : Tablets

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2008-02-12

Date Granted : 2008-11-18

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Gowling Strathy & Henderson

Oxcarbazepine

Peptide Process CMC

Not Confirmed

Gowling Strathy & Henderson

Canada

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2018-02-12

Date Granted : 2008-11-18

Oxcarbazepine

Brand Name : TRILEPTAL

Patent Number : 2277791

Filing Date : 1998-02-12

Strength per Unit : 60mg / ml

Dosage Form : Oral Suspension

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2018-02-12

Date Granted : 2008-11-18

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!